13F

Stock

Aprea Therapeutics, Inc.

APRE · held by 22 managers

Reported value

$1.45M

Holders

22

+0 new · −0 exited

Holders’ est. mark

−$43K

Price effect on 2 books still in the name

Largest holder

$316.1K

AIGH Capital Management LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
AIGH Capital Management LLC370.5K$316.1KHeld
Murchinson Ltd.340.1K$290.1KHeld
SPHERA FUNDS MANAGEMENT LTD.270K$230.3KHeld
Nantahala Capital Management, LLC205.8K$175.5KHeld
DRW Securities, LLC120.7K$102.9KHeld
MORGAN STANLEY77K$65.7K−$40.9KCut−$31.4K
Vanguard58.1K$49.5KHeld
Citadel51K$43.5KHeld
JANE STREET GROUP, LLC46.6K$39.8KHeld
GEODE CAPITAL MANAGEMENT, LLC41K$34.9KHeld
BNP PARIBAS FINANCIAL MARKETS27.3K$23.3KHeld
LPL Financial LLC26.1K$22.2KHeld
XTX Topco Ltd24.3K$20.7KHeld
HighTower Advisors, LLC13.9K$11.8KHeld
BlackRock, Inc.8.5K$7.25KHeld
Tower Research Capital LLC (TRC)7.83K$6.68KHeld
BANK OF AMERICA CORP /DE/3.3K$2.81K−$2.05KCut−$4.36K
UBS Group AG2.46K$2.1KHeld
GROUP ONE TRADING LLC577$492Held
OSAIC HOLDINGS, INC.300$255Held
WealthCollab, LLC158$135Held
SBI Securities Co., Ltd.15$13Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.